Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Coleman

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
"Reports of my death [may be] greatly exaggerated" (adapted from Mark Twain)--in response to Dr. J. M. Brown, IJROBP 32:883-885; 1995C N Coleman
Stem Cells (Dayton, Ohio)|January 1, 1996
Modulating the radiation responseC N Coleman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1993
Beneficial liaisons: radiobiology meets cellular and molecular biologyC N Coleman
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Investing in our future: listening to those who will take us where we need to goC N Coleman
The American Journal of Pediatric Hematology/Oncology|January 1, 1982
Adverse effects of cancer therapy. Risk of secondary neoplasmsC N Coleman
Seminars in Oncology|June 1, 1989
Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. RadiosensitizersC N Coleman
Journal of the National Cancer Institute|May 4, 1988
Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneityC N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
We're from the government and we're here to help youC N Coleman, R Cumberlin
The Journal of Urology|August 1, 1994
Re: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patientsI Kaplan, C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Translational research in radiation oncologyC N Coleman, R L Cumberlin
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
"Reports of my death [may be] greatly exaggerated" (adapted from Mark Twain)--in response to Dr. J. M. Brown, IJROBP 32:883-885; 1995C N Coleman
Stem Cells (Dayton, Ohio)|January 1, 1996
Modulating the radiation responseC N Coleman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1993
Beneficial liaisons: radiobiology meets cellular and molecular biologyC N Coleman
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Investing in our future: listening to those who will take us where we need to goC N Coleman
The American Journal of Pediatric Hematology/Oncology|January 1, 1982
Adverse effects of cancer therapy. Risk of secondary neoplasmsC N Coleman
Seminars in Oncology|June 1, 1989
Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. RadiosensitizersC N Coleman
Journal of the National Cancer Institute|May 4, 1988
Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneityC N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
We're from the government and we're here to help youC N Coleman, R Cumberlin
The Journal of Urology|August 1, 1994
Re: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patientsI Kaplan, C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Translational research in radiation oncologyC N Coleman, R L Cumberlin
Pageof 17